Cilazapril prevents cardiac hypertrophy and postischemic myocardial dysfunction in hyperthyroid rats

Thyroid

Volumn 11, Issue 11, 2001, Pages 1009-1015

  Asahi, T ^a   Shimabukuro, M ^a   Oshiro, Y ^a   Yoshida, H ^a   Takasu, N ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PROPRANOLOL; THYROXINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG EFFECT; HEART CONTRACTION; HEART HYPERTROPHY; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART WEIGHT; HYPERTHYROIDISM; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYMPATHETIC TONE;

EID: 0035185883     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/105072501753271680     Document Type: Article

References (28)

1. Thyroid hormone therapy in cardiovascular disease
2. Thyroid hormone and cardiovascular disease
3. Thyroid hormone and the cardiovascular system
4. Thyrotoxicosis and the heart
5. Abnormal left ventricular function in hyperthyroidism: Evidence for a possible reversible cardiomyopathy
6. Effect of hypoxia and catecholamine stimulation on cardiac performance in the isolated working hyperthyroid rat heart
7. Excess triiodothyronine as a risk factor of coronary events
8. Cardiac hypertrophy as a result of longterm thyroxine therapy and thyrotoxicosis
9. Minimal cardiac effects in asymptomatic athyreotic patients chronically treated with thyrotropin-suppressive doses of L-thyroxine
10. Cardiac hypertrophy induced by thyroid hormone is independent of loading conditions and beta adrenoceptor blockade
11. Thyroxine-induced cardiac hypertrophy: Time course of development and inhibition by propranolol
12. Role of the renin-angiotensin system in cardiac hypertrophy induced in rats by hyperthyroidism
13. Renin-angiotensin system contribution to cardiac hypertrophy in experimental hyperthyroidism: An echocardiographic study
14. Recovery of glycolysis and oxidative metabolism during postischemic reperfusion of hypertrophied rat hearts
15. Regression of cardiac hypertrophy normalizes glucose metabolism and left ventricular function during reperfusion
16. Effects of regression of left ventricular hypertrophy following atenolol or bunazosin therapy on ischemic cardiac function and myocardial metabolism in spontaneously hypertensive rats
17. Effect of regression of cardiac hypertrophy on ischemic myocardial damage in spontaneously hypertensive rats
18. Chronic gliclazide treatment affects basal and post-ischemic cardiac function in diabetic rats
19. Nitric oxide modulates coronary autoregulation in the guinea pig
20. Dose-dependent effect of ANG II-receptor antagonist on myocyte remodeling in rat cardiac hypertrophy
21. Thyroid hormone effects on intracellular calcium and inotropic responses of rat ventricular myocardium
22. The role of calcium in the enhanced myocardial contractility of the hypertrophied rat heart
23. Cardiac hypertrophy impairs recovery from ischaemia because there is a reduced reactive hyperaemic response
24. Triiodothyronine-enhanced left ventricular function after ischemic injury
25. Triiodothyronine improves left ventricular function without oxygen wasting effects after global hypothermic ischemia
26. Enalapril and losartan reduced cardiac mass and improved coronary hemodynamics in SHR
27. Endothelin antagonism in end-organ damage of spontaneously hypertensive rats. Comparison with angiotensin-converting enzyme inhibition and calcium antagonism
28. Failure of propranolol to prevent chronic hyperthyroid induced cardiac hypertrophy and multifocal cellular necrosis in the rat